I have been watching a pattern play out across pharma and healthcare, and I am curious whether others here have seen the same.
Almost every organization now runs an AI pilot. Very few move that pilot into something that actually changes how the business runs. The technology usually works in the demo. Then it quietly stalls.
From what I have seen, the reasons are rarely about the AI model itself. They tend to be more practical:
The underlying data is too fragmented or outdated for the AI to be trusted. Poor HCP data quality alone derails more projects than any modeling limitation.
Compliance and privacy questions slow everything down, especially in regulated markets where DPDP compliant HCP marketing is non-negotiable.
The tool does not fit how people actually work day to day.
No one owns the outcome once the pilot ends.
What I find interesting is that the winners are not always the ones with the most advanced technology. They are often the ones who treat
agentic AI in healthcare as a workflow problem, not a model problem. They pick one painful process, prove value there, and expand from a position of trust.
I would genuinely like to hear from this community:
Have you seen AI projects stall, and what was the real reason?
For those who got past the pilot stage, what made the difference?
Do you think the biggest barrier is data quality, compliance, pharma commercial AI readiness, or something else entirely?
Not looking for vendor pitches, just honest experience. The practical lessons in this space tend to be more useful than the headlines.
Locked
